ROYAL BANK OF CANADA - INTEGRA LIFESCIENCES HLDGS C ownership

INTEGRA LIFESCIENCES HLDGS C's ticker is IART and the CUSIP is 457985208. A total of 255 filers reported holding INTEGRA LIFESCIENCES HLDGS C in Q4 2020. The put-call ratio across all filers is 1.05 and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of INTEGRA LIFESCIENCES HLDGS C
ValueSharesWeighting
Q3 2023$17,818,000
+7.3%
466,577
+15.6%
0.01%
+25.0%
Q2 2023$16,606,000
-25.4%
403,687
+4.1%
0.00%
-33.3%
Q1 2023$22,259,000
-2.6%
387,700
-4.9%
0.01%
-14.3%
Q4 2022$22,848,000
+25.7%
407,475
-5.1%
0.01%
+16.7%
Q3 2022$18,181,000
-22.4%
429,194
-1.1%
0.01%
-14.3%
Q2 2022$23,440,000
-16.6%
433,832
-0.8%
0.01%0.0%
Q1 2022$28,112,000
-41.2%
437,487
-38.7%
0.01%
-36.4%
Q4 2021$47,847,000
-5.5%
714,252
-3.4%
0.01%
-15.4%
Q3 2021$50,651,000
-3.5%
739,638
-3.9%
0.01%
-7.1%
Q2 2021$52,512,000
-6.2%
769,511
-5.0%
0.01%
-12.5%
Q1 2021$55,969,000
-3.4%
810,069
-9.2%
0.02%
-5.9%
Q4 2020$57,923,000
+38.1%
892,214
+0.5%
0.02%
+13.3%
Q3 2020$41,934,000
+3.2%
888,023
+2.7%
0.02%
-6.2%
Q2 2020$40,632,000
+38.8%
864,692
+32.0%
0.02%
+14.3%
Q1 2020$29,265,000
-23.9%
655,135
-0.7%
0.01%0.0%
Q4 2019$38,449,000
+11.2%
659,692
+14.6%
0.01%0.0%
Q3 2019$34,586,000
+26.1%
575,756
+17.2%
0.01%
+27.3%
Q2 2019$27,435,000
+32.4%
491,207
+32.0%
0.01%
+22.2%
Q1 2019$20,729,000
+18.7%
372,032
-3.9%
0.01%
+12.5%
Q4 2018$17,460,000
-39.8%
387,119
-12.1%
0.01%
-33.3%
Q3 2018$29,006,000
-12.9%
440,359
-14.9%
0.01%
-20.0%
Q2 2018$33,321,000
-0.8%
517,308
-14.7%
0.02%0.0%
Q1 2018$33,575,000
-2.4%
606,698
-15.6%
0.02%0.0%
Q4 2017$34,390,000
-29.6%
718,545
-25.7%
0.02%
-34.8%
Q3 2017$48,830,000
-16.5%
967,316
-9.8%
0.02%
-23.3%
Q2 2017$58,477,000
+57.0%
1,072,799
+21.4%
0.03%
+50.0%
Q1 2017$37,240,000
+0.4%
883,906
+104.5%
0.02%0.0%
Q4 2016$37,087,000
-19.0%
432,288
-22.0%
0.02%
-23.1%
Q3 2016$45,776,000
-13.9%
554,531
-16.8%
0.03%
-18.8%
Q2 2016$53,188,000
+5.4%
666,684
-11.0%
0.03%
+3.2%
Q1 2016$50,457,000
-0.8%
749,060
-0.2%
0.03%
-6.1%
Q4 2015$50,855,000
+9.3%
750,307
-4.0%
0.03%
-5.7%
Q3 2015$46,527,000
-5.7%
781,315
+6.7%
0.04%
+2.9%
Q2 2015$49,351,000
+6.3%
732,537
-2.7%
0.03%
+6.2%
Q1 2015$46,418,000
+31.2%
752,936
+15.4%
0.03%
+39.1%
Q4 2014$35,380,000
+10.2%
652,398
+0.9%
0.02%
+4.5%
Q3 2014$32,093,000
+15.7%
646,516
+9.7%
0.02%
+15.8%
Q2 2014$27,746,000
+2.9%
589,590
+0.5%
0.02%
-5.0%
Q1 2014$26,974,000
-1.3%
586,509
+2.4%
0.02%
+5.3%
Q4 2013$27,330,000
+36.5%
572,840
+15.1%
0.02%
+26.7%
Q3 2013$20,026,000
+27.1%
497,545
+15.6%
0.02%
+15.4%
Q2 2013$15,760,000430,2550.01%
Other shareholders
INTEGRA LIFESCIENCES HLDGS C shareholders Q4 2020
NameSharesValueWeighting ↓
Champlain Investment Partners, LLC 5,473,820$305,001,0002.66%
FALCON POINT CAPITAL, LLC 80,729$4,498,0002.45%
Tributary Capital Management, LLC 508,838$28,352,0002.06%
Broadfin Capital, LLC 141,572$7,888,0001.63%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 182,585$10,174,0001.57%
Sapience Investments, LLC 132,810$7,400,0000.98%
VAUGHAN NELSON INVESTMENT MANAGEMENT, L.P. 1,110,177$61,860,0000.83%
Bellevue Group AG 222,350$12,389,0000.68%
Capital International Sarl 74,325$4,141,0000.52%
Hood River Capital Management LLC 180,772$10,073,0000.51%
View complete list of INTEGRA LIFESCIENCES HLDGS C shareholders